Andrieu C - Search Results

1

Botulinum toxin type A inhibits the growth of LNCaP human prostate cancer cells in vitro and in vivo.

Karsenty G, Rocha J, Chevalier S, Scarlata E, Andrieu C, Zouanat FZ, Rocchi P, Giusiano S, Elzayat EA, Corcos J. Karsenty G, et al. Among authors: andrieu c. Prostate. 2009 Aug 1;69(11):1143-50. doi: 10.1002/pros.20958. Prostate. 2009. PMID: 19399787

2

Heat shock protein 27 confers resistance to androgen ablation and chemotherapy in prostate cancer cells through eIF4E.

Andrieu C, Taieb D, Baylot V, Ettinger S, Soubeyran P, De-Thonel A, Nelson C, Garrido C, So A, Fazli L, Bladou F, Gleave M, Iovanna JL, Rocchi P. Andrieu C, et al. Oncogene. 2010 Apr 1;29(13):1883-96. doi: 10.1038/onc.2009.479. Epub 2010 Jan 18. Oncogene. 2010. PMID: 20101233

3

TP53INP1 overexpression in prostate cancer correlates with poor prognostic factors and is predictive of biological cancer relapse.

Giusiano S, Garcia S, Andrieu C, Dusetti NJ, Bastide C, Gleave M, Taranger-Charpin C, Iovanna JL, Rocchi P. Giusiano S, et al. Among authors: andrieu c. Prostate. 2012 Feb 1;72(2):117-28. doi: 10.1002/pros.21412. Epub 2011 May 2. Prostate. 2012. PMID: 21538421

4

OGX-427 inhibits tumor progression and enhances gemcitabine chemotherapy in pancreatic cancer.

Baylot V, Andrieu C, Katsogiannou M, Taieb D, Garcia S, Giusiano S, Acunzo J, Iovanna J, Gleave M, Garrido C, Rocchi P. Baylot V, et al. Among authors: andrieu c. Cell Death Dis. 2011 Oct 20;2(10):e221. doi: 10.1038/cddis.2011.104. Cell Death Dis. 2011. PMID: 22012255 Free PMC article.

5

TP53INP1 as new therapeutic target in castration-resistant prostate cancer.

Giusiano S, Baylot V, Andrieu C, Fazli L, Gleave M, Iovanna JL, Taranger-Charpin C, Garcia S, Rocchi P. Giusiano S, et al. Among authors: andrieu c. Prostate. 2012 Sep 1;72(12):1286-94. doi: 10.1002/pros.22477. Epub 2011 Dec 27. Prostate. 2012. PMID: 22213058

6

Targeting TCTP as a new therapeutic strategy in castration-resistant prostate cancer.

Baylot V, Katsogiannou M, Andrieu C, Taieb D, Acunzo J, Giusiano S, Fazli L, Gleave M, Garrido C, Rocchi P. Baylot V, et al. Among authors: andrieu c. Mol Ther. 2012 Dec;20(12):2244-56. doi: 10.1038/mt.2012.155. Epub 2012 Aug 14. Mol Ther. 2012. PMID: 22893039 Free PMC article.

7

Hsp27 as a therapeutic target in cancers.

Acunzo J, Andrieu C, Baylot V, So A, Rocchi P. Acunzo J, et al. Among authors: andrieu c. Curr Drug Targets. 2014 Apr;15(4):423-31. doi: 10.2174/13894501113146660230. Curr Drug Targets. 2014. PMID: 24138636 Review.

8

The functional landscape of Hsp27 reveals new cellular processes such as DNA repair and alternative splicing and proposes novel anticancer targets.

Katsogiannou M, Andrieu C, Baylot V, Baudot A, Dusetti NJ, Gayet O, Finetti P, Garrido C, Birnbaum D, Bertucci F, Brun C, Rocchi P. Katsogiannou M, et al. Among authors: andrieu c. Mol Cell Proteomics. 2014 Dec;13(12):3585-601. doi: 10.1074/mcp.M114.041228. Epub 2014 Oct 2. Mol Cell Proteomics. 2014. PMID: 25277244 Free PMC article.

9

Heat shock protein 27 phosphorylation state is associated with cancer progression.

Katsogiannou M, Andrieu C, Rocchi P. Katsogiannou M, et al. Among authors: andrieu c. Front Genet. 2014 Oct 6;5:346. doi: 10.3389/fgene.2014.00346. eCollection 2014. Front Genet. 2014. PMID: 25339975 Free PMC article. Review.

10

The hallmarks of castration-resistant prostate cancers.

Katsogiannou M, Ziouziou H, Karaki S, Andrieu C, Henry de Villeneuve M, Rocchi P. Katsogiannou M, et al. Among authors: andrieu c. Cancer Treat Rev. 2015 Jul;41(7):588-97. doi: 10.1016/j.ctrv.2015.05.003. Epub 2015 May 9. Cancer Treat Rev. 2015. PMID: 25981454 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

104 results

Search Page

Filters